INTRODUCTION
============

Osteoporosis is a disease of the bone metabolism characterized by loss of the bone mass and microarchitectural alterations which results in bone fragility and increased risk of fractures.\[[@B1]\] The representative diagnostic tool of osteoporosis is a measurement of bone mineral density (BMD) and biochemical markers.

One of the most common methods of BMD measurements is dual energy X-ray absorptiometry (DXA). It is a safe, accurate and precise technique. Various devices are available, and the values of measurement may differ among them, for technical reasons.\[[@B2],[@B3]\] Different results of BMD measurement using a number of different types of devices are difficult to use clinical practice when patients are followed on different machines.\[[@B4]\]

For appropriate treatment and study, we need quality control and calibration of the devices by measurement of phantoms.\[[@B5]\] The European Spine Phantom (ESP) had been developed as a universal standard for instruments measuring bone density. The ESP is composed of three semi-anthropomorphic hydroxyapatite vertebrae of varying densities surrounded by soft tissue equivalent plastic designed to resemble human bone and soft tissue when scanned on bone densitometers.\[[@B6]\] The ESP has been developed by an independent group under the auspices of the Comité d\'Actions Concertés-BioMedical Engineering (COMAC-BME) organization,\[[@B7],[@B8],[@B9]\] for use with different types of DXA devices.\[[@B6]\] This phantom has been used for standardization of BMD results.\[[@B7]\] So far, comparison studies using world widely popular several bone densitometers were reported. However, there is no comparison study including regional bone densitometry. Therefore, the purpose of this study was to evaluate discrepancy and standardizations of DXA devices from three manufactures using a ESP.

METHODS
=======

Thirty-two centers equipped with DXA devices participated in this study. These centers were distributed throughout the country. Ten centers had 10 Hologic Discovery-W devices (Hologic Inc., Waltham, MA, USA). Ten centers had 10 Osteosys Dexxum-T devices (OsteoSys, Seoul, Korea). Twelve centers had 16 Lunar Prodigy advance devices (GE Healthcare, Madison, WI, USA).

A single ESP (no. 126) was used to compare the results of different devices. The ESP is a semianthropomorphic phantom, comprising three vertebralike structures of different sizes and densities. The three vertebrae represent low (L1), medium (L2), and high (L3) densities, with actual BMD values of 0.496 g/cm^2^, 0.990 g/cm^2^, and 1.499 g/cm^2^, respectively. According to Kolta et al.\'s methods,\[[@B4]\] the phantom was scanned 5 times without repositioning on each device. BMD (g/cm^2^), bone mineral content (BMC, g) and area (cm^2^) were collected for each vertebra (L1, L2, L3) and for the three together (L1-L3). We compared the BMD and BMC results on different types of device using ANOVA and Tukey post hoc test. To assess the accuracy of measurement, individual BMD values observed on each device were compared with actual BMD and BMC values of the phantom. To assess precision we plotted the differences between each replicate measurement of BMD and the estimated true value for a particular manufacturer, and calculated the limits of agreement as defined by Bland and Altman.\[[@B7]\] The true value was estimated by the average of all replicate measurements for each manufacturer. In addition, the mean values of the coefficient of variation (CVsd), for each type of device, were calculated for BMD and BMC for each vertebra as well as for the three vertebrae together, using the root mean square average.\[[@B8],[@B10]\]

RESULTS
=======

The average (±standard deviation \[SD\]) results of BMD and BMC of L1, L2, L3, and L1-L3 for three devices was described in [Table 1](#T1){ref-type="table"}. There was significant difference between BMD values on three devices ([Table 1](#T1){ref-type="table"}).

BMD values of L1, L2, and L3 on three types of device were different from their actual values ([Fig. 1](#F1){ref-type="fig"}). For Lunar devices there was, on average, 22% (0.109 g/cm^2^), 8.3% (0.082 g/cm^2^), and 5% (0.075 g/cm^2^) overestimation for low (L1) BMD values, medium (L2), and high (L3) BMD values. For Hologic devices there was, on average, 6% (0.03 g/cm^2^) overestimation for low (L1) BMD values, and 5% (0.05 g/cm^2^) and 6.2% (0.093 g/cm^2^) underestimation for medium (L2) and high (L3) BMD values. For Osteosys devices there was, on average, 12.7% (0.063 g/cm^2^), 6.3% (0.062 g/cm^2^), and 5% (0.075 g/cm^2^) underestimation for L1, L2, and L3, respectively.

The limits of agreement, as defined by Bland and Altman, for Hologic devices were ±0.024, ±0.045, ±0.042, and ±0.026 g/cm^2^ for L1, L2, and L3 respectively. For Lunar devices these limits were ±0.035, ±0.062, ±0.122 g/cm^2^ for L1, L2, and L3. For Osteosys devices these limits were ±0.050, ±0.083, ±0.190 g/cm^2^ for L1, L2, and L3.

Differences in extreme results between devices from the same manufacturer were on average 1.4 %, 2.8%, and 5.2% for L1-L3 BMD, 1.6%, 7.7%, and 4.9% for L1-L3 BMC for Hologic, Lunar, and Osteosys devices respectively. These differences reached up to 3.95%, 3.77%, and 10.8% for low (L1) BMD on Hologic, Lunar, and Osteosys devices respectively. By comparing these extreme results with the mean values for devices from the same manufacturer, they ranged from -2.3% to +5.0%, -11.5 to +3.6%, and -9.8% to +6.5% on Hologic, Lunar, and Osteosys devices respectively. The mean CVsd values are given in [Table 2](#T2){ref-type="table"}. For L1-L3 BMD they were 0.01%, 0.78%, and 2.46% for Lunar, Hologic, and Osteosys devices respectively.

DISCUSSION
==========

In the *in vitro* ESP study, the BMD comparison shows that BMD result of three different devices are significant different between three devices. However, the accuracy and precision of three devices are moderately satisfaction, as are the limits of agreement among devices.

Although difference of measurement results between Lunar and Hologic devices is well established, BMD results of Osteosys devices in this study are also different from two other devices.\[[@B3],[@B4]\] These findings are corresponded with other studies. They suggested that the reason of these differences were the difference in edge detection algorithms and devices for scan method.\[[@B6]\] For example, Hologic devices use a fixed threshold of 0.2 g/cm^2^ and this excludes less of the transverse processes and Lunar devices use a different algorithm incorporating the first derivative of pixels at bone edge, thus eliminating more or less low-density bone.\[[@B9]\] In addition, Fan beam scanners do not measure area directly as do pencil beam scanners. Osteosys device used pencil beam as scan methods. Other two devices used Fan-beam system to measure BMD.\[[@B11],[@B12]\]

According to the agreement between devices, large measurement errors in L3 were observed. In the usual range of BMD (0.5 to 1.0 g/cm^2^) the limits of agreement were similar for three manufacturers.\[[@B4]\] Although the mean CVsd values of BMD for Lunar and Hologic devices are comparable to those found by other authors,\[[@B2],[@B4],[@B6]\] the mean CVsd values of BMD for Osteosys device is slightly wider than other two devices. To minimize range of CVsd, more accurate calibration and quality control are mandatory.

In this study, BMD data of three devices are difficult to generalize BMD results among three devices. So far, cross-calibration formulae for Lunar and Hologic devices have been developed.\[[@B2],[@B10]\] This is particularly useful for epidemiologic studies and therapeutic trials that deal with groups of patients.\[[@B13],[@B14]\] Further cross calibration studies for three devices are required to evaluate a comparison of BMD measurement.

This study has a limitation. This study is *in vitro* ESP study and sample size of this study is not enough to generalize the results. Further study is necessary to calculate cross-calibration formula for three different devices.

In conclusion, the BMD comparison in this study demonstrates that BMD result of three different devices are significant different between three devices. However, the accuracy and precision of three devices are moderately satisfaction. Differences of BMD between three devices are necessary to BMD standardization.
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###### Bone mineral density differences of three devices
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Data were presented as mean±standard deviation, and compared using ANOVA and Tukey post hoc test.

^a)^*P*\<0.05 compared with Hologic. ^b)^*P*\<0.05 compared between Lunar and Osteosys.

BMC, bone mineral content.

###### Coefficients of variation (CVsd, %) of the bone mineral density and bone mineral content L1, L2, L3, and L1 to L3 for Hologic, Lunar, and Osteosys devices
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BMC, bone mineral content.
